用于中枢神经系统肿瘤病理诊断的分子工具。
Molecular tools for the pathologic diagnosis of central nervous system tumors.
作者信息
Priesterbach-Ackley Loudy P, Wesseling Pieter, Snijders Tom J, de Vos Filip Y F L, de Leng Wendy W J
机构信息
Department of Pathology, University Medical Center Utrecht, The Netherlands.
Department of Pathology, Princess Máxima Center for Pediatric Oncology and University Medical Center Utrecht, The Netherlands.
出版信息
Neurooncol Pract. 2019 Jan;6(1):4-16. doi: 10.1093/nop/npy041. Epub 2018 Nov 5.
Abstract
Molecular diagnostics currently has a crucial role in neuro-oncological patient care. (Epi)genetic assays testing for point mutations, copy number variations, gene fusions, translocations, and methylation status are of main diagnostic interest in neuro-oncology. Multiple assays have been developed for this purpose, ranging from single gene tests to high-throughput, integrated techniques enabling detection of multiple genetic aberrations in a single workflow. This review describes the nature of the simpler and more complex assays for molecular diagnostics of tumors of the central nervous system and briefly discusses their strengths and weaknesses.
摘要
分子诊断目前在神经肿瘤患者护理中起着关键作用。检测点突变、拷贝数变异、基因融合、易位和甲基化状态的（表观）遗传学检测是神经肿瘤学主要的诊断关注点。为此已经开发了多种检测方法，从单基因检测到高通量集成技术，能够在单个工作流程中检测多种基因异常。本文综述描述了用于中枢神经系统肿瘤分子诊断的较简单和较复杂检测方法的性质，并简要讨论了它们的优缺点。
相似文献
1
Molecular tools for the pathologic diagnosis of central nervous system tumors.用于中枢神经系统肿瘤病理诊断的分子工具。
Neurooncol Pract. 2019 Jan;6(1):4-16. doi: 10.1093/nop/npy041. Epub 2018 Nov 5.
2
The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care.中枢神经系统肿瘤甲基化分类器改变了神经肿瘤学的实践，有助于对具有挑战性的脑肿瘤进行诊断，并直接影响患者的护理。
Clin Epigenetics. 2019 Dec 5;11(1):185. doi: 10.1186/s13148-019-0766-2.
3
Current status of DNA methylation profiling in neuro-oncology as a diagnostic support tool: A review.DNA甲基化谱分析在神经肿瘤学中作为诊断辅助工具的现状：综述
Neurooncol Pract. 2023 Jul 22;10(6):518-526. doi: 10.1093/nop/npad040. eCollection 2023 Dec.
4
Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.分子神经肿瘤学的应用——弥漫性胶质瘤综合诊断及新兴分子实体综述
Diagn Pathol. 2019 Apr 9;14(1):29. doi: 10.1186/s13000-019-0802-8.
5
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets.在常规脑肿瘤诊断中进行下一代测序可实现综合诊断并确定可行的靶点。
Acta Neuropathol. 2016 Jun;131(6):903-10. doi: 10.1007/s00401-015-1519-8. Epub 2015 Dec 15.
6
A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.2015年预测性分子病理学及其在靶向癌症治疗中的作用更新：聚焦临床相关性的综述
Cancer Gene Ther. 2015 Sep;22(9):417-30. doi: 10.1038/cgt.2015.39. Epub 2015 Sep 11.
7
Top ten discoveries of the year: Neurooncology.年度十大发现：神经肿瘤学。
Free Neuropathol. 2020 Feb 26;1:8. doi: 10.17879/freeneuropathology-2020-2671. eCollection 2020 Jan.
8
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions.在神经病理学诊断中，对福尔马林固定石蜡包埋标本进行常规 RNA 测序可鉴定出具有诊断和治疗意义的基因融合。
Acta Neuropathol. 2019 Nov;138(5):827-835. doi: 10.1007/s00401-019-02039-3. Epub 2019 Jul 5.
9
Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.基于基因突变分析、拷贝数改变和 DNA 甲基化分析的中枢神经系统黑色素细胞肿瘤的综合基因组分类。
Clin Cancer Res. 2018 Sep 15;24(18):4494-4504. doi: 10.1158/1078-0432.CCR-18-0763. Epub 2018 Jun 11.
10
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience.DNA 甲基化和基于拷贝数的中枢神经系统肿瘤诊断的实际应用：海德堡经验。
Acta Neuropathol. 2018 Aug;136(2):181-210. doi: 10.1007/s00401-018-1879-y. Epub 2018 Jul 2.
引用本文的文献
1
A clinically feasible algorithm for the parallel detection of glioma-associated copy number variation markers based on shallow whole genome sequencing.基于浅层全基因组测序的脑胶质瘤相关拷贝数变异标志物并行检测的临床可行算法。
J Pathol Clin Res. 2024 Nov;10(6):e70005. doi: 10.1002/2056-4538.70005.
2
Top ten discoveries of the year: Neurooncology.年度十大发现：神经肿瘤学。
Free Neuropathol. 2020 Feb 26;1:8. doi: 10.17879/freeneuropathology-2020-2671. eCollection 2020 Jan.
3
Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics.2021 年世界卫生组织脑肿瘤分类：NGS 在常规诊断中的优势优于 IHC。
Mol Diagn Ther. 2022 Nov;26(6):699-713. doi: 10.1007/s40291-022-00612-3. Epub 2022 Sep 2.
4
Ultra-rapid somatic variant detection via real-time targeted amplicon sequencing.通过实时靶向扩增子测序进行超快速体突变检测。
Commun Biol. 2022 Jul 15;5(1):708. doi: 10.1038/s42003-022-03657-6.
5
Determination of and Gene Mutations in Glial Tumors.胶质肿瘤中 和 基因突变的测定。
In Vivo. 2022 Jul-Aug;36(4):1694-1702. doi: 10.21873/invivo.12881.
6
Next-Generation Sequencing Analysis of ctDNA for the Detection of Glioma and Metastatic Brain Tumors in Adults.用于检测成人胶质瘤和转移性脑肿瘤的循环肿瘤DNA的下一代测序分析
Front Neurol. 2020 Aug 21;11:544. doi: 10.3389/fneur.2020.00544. eCollection 2020.
7
Molecular pathology of tumors of the central nervous system.中枢神经系统肿瘤的分子病理学。
Ann Oncol. 2019 Aug 1;30(8):1265-1278. doi: 10.1093/annonc/mdz164.
8
The ABCs of molecular diagnostic testing of CNS tumors: acceptance, benefits, costs.中枢神经系统肿瘤分子诊断检测的基础知识：接受度、益处、成本。
Neuro Oncol. 2019 May 6;21(5):559-561. doi: 10.1093/neuonc/noz027.
本文引用的文献
1
cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".cIMPACT-NOW更新3：“弥漫性星形细胞胶质瘤，IDH野生型，具有胶质母细胞瘤分子特征，WHO四级”的推荐诊断标准。
Acta Neuropathol. 2018 Nov;136(5):805-810. doi: 10.1007/s00401-018-1913-0. Epub 2018 Sep 26.
2
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience.DNA 甲基化和基于拷贝数的中枢神经系统肿瘤诊断的实际应用：海德堡经验。
Acta Neuropathol. 2018 Aug;136(2):181-210. doi: 10.1007/s00401-018-1879-y. Epub 2018 Jul 2.
3
DNA methylation-based reclassification of olfactory neuroblastoma.基于 DNA 甲基化的嗅神经母细胞瘤重新分类。
Acta Neuropathol. 2018 Aug;136(2):255-271. doi: 10.1007/s00401-018-1854-7. Epub 2018 May 5.
4
Comparative assessment of three methods to analyze MGMT methylation status in a series of 350 gliomas and gangliogliomas.对350例胶质瘤和神经节胶质瘤系列中三种分析MGMT甲基化状态方法的比较评估。
Pathol Res Pract. 2017 Dec;213(12):1489-1493. doi: 10.1016/j.prp.2017.10.007. Epub 2017 Oct 10.
5
CNS embryonal tumours: WHO 2016 and beyond.中枢神经系统胚胎性肿瘤：2016 年 WHO 分类及其他
Neuropathol Appl Neurobiol. 2018 Feb;44(2):151-162. doi: 10.1111/nan.12443.
6
WHO 2016 Classification of gliomas.世界卫生组织 2016 年版《脑肿瘤分类》。
Neuropathol Appl Neurobiol. 2018 Feb;44(2):139-150. doi: 10.1111/nan.12432.
7
Integrating RNA sequencing into neuro-oncology practice.将RNA测序整合到神经肿瘤学实践中。
Transl Res. 2017 Nov;189:93-104. doi: 10.1016/j.trsl.2017.06.013. Epub 2017 Jul 8.
8
Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing.使用实时纳米孔测序对脑肿瘤进行同日基因组和表观基因组诊断。
Acta Neuropathol. 2017 Nov;134(5):691-703. doi: 10.1007/s00401-017-1743-5. Epub 2017 Jun 21.
9
WHO 2016 classification: changes and advancements in the diagnosis of miscellaneous primary CNS tumours.WHO 2016 分类：中枢神经系统原发性肿瘤诊断中的变化和进展。
Neuropathol Appl Neurobiol. 2018 Feb;44(2):163-171. doi: 10.1111/nan.12397.
10
Influence of decalcification procedures on immunohistochemistry and molecular pathology in breast cancer.脱钙程序对乳腺癌免疫组织化学和分子病理学的影响
Mod Pathol. 2016 Dec;29(12):1460-1470. doi: 10.1038/modpathol.2016.116. Epub 2016 Aug 26.
Zotero 插件